- Home
- FTFT vs BOLT Comparison
FTFT vs BOLT Comparison
Compare FTFT & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- BOLT
- Stock Information
- Founded
- FTFT N/A
- BOLT 2015
- Country
- FTFT United States
- BOLT United States
- Employees
- FTFT N/A
- BOLT N/A
- Industry
- FTFT Business Services
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- FTFT Consumer Discretionary
- BOLT Health Care
- Exchange
- FTFT Nasdaq
- BOLT Nasdaq
- Market Cap
- FTFT 11.0M
- BOLT 11.5M
- IPO Year
- FTFT N/A
- BOLT 2021
- Fundamental
- Price
- FTFT $1.40
- BOLT $4.46
- Analyst Decision
- FTFT
- BOLT Buy
- Analyst Count
- FTFT 0
- BOLT 4
- Target Price
- FTFT N/A
- BOLT $34.00
- AVG Volume (30 Days)
- FTFT 67.3K
- BOLT 22.9K
- Earning Date
- FTFT 11-19-2025
- BOLT 11-14-2025
- Dividend Yield
- FTFT N/A
- BOLT N/A
- EPS Growth
- FTFT N/A
- BOLT N/A
- EPS
- FTFT N/A
- BOLT N/A
- Revenue
- FTFT $2,368,206.00
- BOLT $4,167,000.00
- Revenue This Year
- FTFT N/A
- BOLT N/A
- Revenue Next Year
- FTFT N/A
- BOLT N/A
- P/E Ratio
- FTFT N/A
- BOLT N/A
- Revenue Growth
- FTFT N/A
- BOLT N/A
- 52 Week Low
- FTFT $1.01
- BOLT $4.42
- 52 Week High
- FTFT $5.70
- BOLT $13.40
- Technical
- Relative Strength Index (RSI)
- FTFT 30.38
- BOLT 31.74
- Support Level
- FTFT $1.25
- BOLT $5.65
- Resistance Level
- FTFT $2.22
- BOLT $5.93
- Average True Range (ATR)
- FTFT 0.16
- BOLT 0.34
- MACD
- FTFT -0.08
- BOLT -0.17
- Stochastic Oscillator
- FTFT 12.11
- BOLT 2.07
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.